Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10374	Companies
216189	Keywords
145888	Articles
114464	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 11/04/2024 at 14:35, 1 year 6 months ago

Crofelemer Shows Promise in Managing Cancer Therapy-Related Diarrhea in Breast Cancer Patients

Crofelemer Jaguar Health OnTarget Trial Breast Cancer SABCS
BRIEF

published on 11/04/2024 at 14:35, 1 year 6 months ago

Crofelemer se révèle prometteur dans la prise en charge de la diarrhée liée au traitement du cancer chez les patientes atteintes d'un cancer du sein

Crofelemer Santé Jaguar Essai OnTarget Cancer Du Sein SABCS
PRESS RELEASE

published on 11/04/2024 at 14:30, 1 year 6 months ago

Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS)
Napo Pharmaceuticals announces acceptance of late-breaking abstract on crofelemer results for breast cancer patients in OnTarget trial, presented at SABCS 2024

Napo Pharmaceuticals Crofelemer OnTarget Trial Breast Cancer Late-breaking Abstract
BRIEF

published on 10/29/2024 at 15:05, 1 year 6 months ago

Jaguar Health's Crofelemer Shows Promise in Chronic Refractory Diarrhea Treatment

Crofelemer Jaguar Health Clinical Studies Functional Diarrhea IBS-D Treatment
BRIEF

published on 10/29/2024 at 15:05, 1 year 6 months ago

Le Crofelemer de Jaguar Health s'avère prometteur dans le traitement de la diarrhée chronique réfractaire

Crofelemer Santé Jaguar Études Cliniques Diarrhée Fonctionnelle Traitement Du Syndrome Du Côlon Irritable (SCI-D)
PRESS RELEASE

published on 10/29/2024 at 15:00, 1 year 6 months ago

Significant Positive Results with Jaguar Health's Crofelemer for Chronic Refractory Diarrhea in IBS-D, Presented at American College of Gastroenterology Annual Meeting
Napo Pharmaceuticals announces abstracts for two investigator-initiated studies on crofelemer for chronic refractory diarrhea patients, presented at ACG 2024. Jaguar CEO Lisa Conte comments on crofelemer's clinical robustness and impact on IBS-D patients

Napo Pharmaceuticals Crofelemer IBS-D Chronic Refractory Diarrhea ACG 2024
BRIEF

published on 10/16/2024 at 14:35, 1 year 6 months ago

Jaguar Health Launches Gelclair for Oral Mucositis in the U.S.

Cancer Treatment Jaguar Health Gelclair Oral Mucositis Prescription Product
BRIEF

published on 10/16/2024 at 14:35, 1 year 6 months ago

Jaguar Health lance Gelclair pour la mucosite buccale aux États-Unis

Traitement Du Cancer Santé Jaguar Gelclair Mucite Buccale Produit Sur Ordonnance
PRESS RELEASE

published on 10/16/2024 at 14:30, 1 year 6 months ago

Jaguar Health Launches FDA-Approved Oral Mucositis Prescription Product Gelclair in the U.S.
Jaguar Health, Inc. announces the commercial launch of FDA-approved oral mucositis prescription product Gelclair in the U.S. to provide pain relief for cancer patients

Jaguar Health FDA-approved Gelclair Oral Mucositis Cancer Supportive Care
BRIEF

published on 10/11/2024 at 22:20, 1 year 6 months ago

Jaguar Health Announces Employee Inducement Grants

Pharmaceuticals Jaguar Health RSUs Employee Grants Nasdaq Rule

Accesswire

Published on 05/09/2026 at 01:55, 2 days 2 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 2 days 2 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 2 days 2 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 days 3 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 2 days 4 hours ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/10/2026 at 16:05, 11 hours 51 minutes ago

RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 13 hours 56 minutes ago

MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 16 hours 11 minutes ago

Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 8 hours ago

LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 2 days 7 hours ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations

Les Echos

Published on 05/07/2026 at 19:15, 3 days 8 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 8 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 8 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 8 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 8 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE